| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589219 2,5-bis-diamine-[1,4]benzoquinonic derivatives, useful for the treatment of alzheimer's disease, method for preparing them and intermediates of said method |
| 09/15/2009 | US7589217 Yield improvement in the production of maleic anhydride |
| 09/15/2009 | US7589127 Aminoalkylphenols, methods of using and making the same |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589089 Inhibitors for GlyT-1 |
| 09/13/2009 | CA2625511A1 Process for the direct production of esters of carboxylic acids from fermentation broths |
| 09/11/2009 | WO2009110520A1 Heterocyclic compound |
| 09/11/2009 | WO2009110402A1 Method for producing paraxylene |
| 09/11/2009 | WO2009110217A1 Hydroxyapatite with silver supported on the surface thereof |
| 09/11/2009 | WO2009048152A3 Unsaturated imine compound and use thereof for pest control |
| 09/11/2009 | WO2009044143A4 Process for preparing benzofurans |
| 09/11/2009 | WO2009021126A9 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 09/11/2009 | WO2009015067A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/10/2009 | US20090227790 A kit for treating a disorder characterized by loss of dopaminergic and/or motoneurons, for treating Parkinson's disease, amyotrophic lateral sclerosis (ALS), or limiting damage to neuronal cells by Parkinsonian conditions |
| 09/10/2009 | US20090227743 Polymer-supported metal complex catalyst |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/09/2009 | EP2098519A1 Process for the synthesis of ramelteon and its intermediates |
| 09/09/2009 | EP2098120A2 2-alkyl-cycloalk(en) yl-carboxamides |
| 09/09/2009 | EP2097399A2 Novel inhibitors of chymase |
| 09/09/2009 | EP1881958B1 Diacylglycerol acyltransferase inhibitors |
| 09/09/2009 | CN101528722A Method for preparing crystalline 3-0-alkyl-ascorbic acid |
| 09/09/2009 | CN101528721A Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one |
| 09/09/2009 | CN101525322A New technology for synthesizing Corey lactonic acid by pan boiling method |
| 09/09/2009 | CN101525291A Green asymmetric synthesis method of chiral bicyclics compound |
| 09/09/2009 | CN100537558C Method for extracting gibberellic acid GA4+7 from gibberellic acid fermentation liquor |
| 09/09/2009 | CN100537557C Pyrethroid pesticide |
| 09/09/2009 | CN100537556C Anomeric derivatives of monosaccharides |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/08/2009 | US7585901 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers; dental materials, in particular as dental adhesives, fixing cements or filling composites; low polymerization shrinkage, good mechanical properties |
| 09/08/2009 | US7585891 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides |
| 09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585391 Comprises aqueous emulsion of an alkenyl succinic anhydride(ASA) wherein ASA incorporates a maximum of 1% by weight of polymeric residues; provides enhanced resistance to penetration of edges of paper and board by agents such as hot hydrogen peroxide and lactic acid |
| 09/03/2009 | WO2009107327A1 Monomer having electron-withdrawing substituent and lactone skeleton, polymeric compound, and photoresist composition |
| 09/03/2009 | WO2009106966A1 Process for preparing ramelteon. |
| 09/03/2009 | WO2009105906A1 Flavor molecules |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221661 Phosphodiesterase 4 inhibitors |
| 09/03/2009 | US20090221643 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP2096101A1 Method for producing ketones from alpha-oxocarboxylates and aryl bromides |
| 09/02/2009 | EP2095875A1 Homogeneous asymmetric hydrogenation catalyst |
| 09/02/2009 | EP2094643A2 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 09/02/2009 | EP2094633A1 Hydrofluoroeth r compounds and processes for their preparation and use |
| 09/02/2009 | CN101522655A Taste-improving agent and food or drink containing the same |
| 09/02/2009 | CN101522654A Process for the preparation of gamma-butyrolactones |
| 09/02/2009 | CN101520645A Multivariable process controller and methodology for controlling a catalyzed chemical reaction |
| 09/02/2009 | CN101519392A Compound treating diabetes and relevant complicating diseases and preparation method and application thereof |
| 09/02/2009 | CN101519368A Small molecule entry inhibitors |
| 09/01/2009 | US7582782 Organic compounds |
| 09/01/2009 | US7582780 Method for the separation of intermediates which may be used for the preparation of escitalopram |
| 09/01/2009 | US7582779 Processes and intermediates for the preparations of prostaglandins |
| 09/01/2009 | US7582778 Podophyllotoxin |
| 09/01/2009 | US7582766 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; (N-benzyl)phenylacetamides or N-benzyl-N'-phenyl ureas |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 08/27/2009 | WO2009105722A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009104605A1 Novel intermediate for synthesis of ascofranone having various physiological activities, and novel shortened total synthesis method for ascofranone using the same |
| 08/27/2009 | WO2006087393A3 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders |
| 08/27/2009 | US20090215730 Antineoplastic compounds and pharmaceutical compositions thereof |
| 08/27/2009 | US20090215624 Alkoxyalkyl Spirocyclic Tetramic Acids and Tetronic Acids |
| 08/27/2009 | US20090215623 Insecticidal 3-acylaminobenzanilides |
| 08/27/2009 | US20090214452 Arginine Heteromers for Topical Administration |
| 08/27/2009 | CA2716349A1 Methods for inhibiting drug degradation |
| 08/27/2009 | CA2716348A1 Diamide inhibitors of cytochrome p450 |
| 08/27/2009 | CA2716347A1 Amino acid inhibitors of cytochrome p450 |
| 08/27/2009 | CA2716332A1 Compounds and compositions as modulators of gpr119 activity |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2091933A1 Dihydrobenzofuranyl derivatives and methods of their use |
| 08/26/2009 | EP2091929A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 08/26/2009 | EP1701947B1 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |
| 08/26/2009 | EP1173431B2 Method for the preparation of citalopram |
| 08/26/2009 | CN101516844A 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 08/26/2009 | CN101516837A Sulfonamide derivatives |
| 08/26/2009 | CN101514193A Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl) propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide |
| 08/26/2009 | CN101514168A Synthesis of 2-hydroxy-n,n-dimethyl-3-[[2-[1(r)-(5-methyl-2-furanyl) propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide |
| 08/26/2009 | CN101514141A Synthetic method for allyl alcohol-like compound |
| 08/26/2009 | CN101513402A Antiviral agent |
| 08/26/2009 | CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same |
| 08/26/2009 | CN100532340C Indane compounds with negative dielectric anisotropy |
| 08/25/2009 | US7579490 heating and chemical reduction in presence of a catalyst system consisting of nickel and a zirconium promoter to form 2,5-bis(hydroxymethyl)tetrahydrofuran; use for environmentally friendly latex paints, reduce of VOC |
| 08/25/2009 | US7579489 Acid-catalyzed dehydration of fructose in 1-methyl-2-pyrrolidinone, dimethylacetamide, or dimethylformamide with a catalyst; end-capped polyethylene glycol eliminates the formation of undesirable PEG-HMF ethers |
| 08/25/2009 | US7579488 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; [(2-{1-[4-(3,3-Dimethyl-2-oxo-butoxy)-3-methyl-phenyl]-1-ethylpropyl}-benzofuran-5-carbonyl)-amino]-acetic acid |
| 08/25/2009 | US7579485 Reacting amide in aqueous solution; cyclization |
| 08/25/2009 | US7579484 Method for the production of monoalkylamino ketones |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | CA2455097C Enzyme inhibition immunoassay based on impdh inhibition by mpa |
| 08/25/2009 | CA2418280C Two-stage process for the hydrogenation of maleic acid to 1,4-butanediol |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/20/2009 | WO2009101885A1 Polyimide |